Skip to main content
logo
Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.660
+0.090 (3.50%)
At close: Mar 4, 2026, 4:00 PM EST
2.700
+0.040 (1.50%)
After-hours: Mar 4, 2026, 7:43 PM EST

Absci Revenue

Absci had revenue of $378.00K in the quarter ending September 30, 2025, a decrease of -77.78%. This brings the company's revenue in the last twelve months to $2.82M, down -33.09% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.

Revenue (ttm)
$2.82M
Revenue Growth
-33.09%
P/S Ratio
142.09
Revenue / Employee
$17,930
Employees
157
Market Cap
399.99M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.53M-1.18M-20.71%
Dec 31, 20235.72M-29.00K-0.50%
Dec 31, 20225.75M965.00K20.18%
Dec 31, 20214.78M2.00K0.04%
Dec 31, 20204.78M2.72M132.04%
Dec 31, 20192.06M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Niagen Bioscience124.71M
Century Therapeutics113.34M
Enanta Pharmaceuticals66.98M
Bicycle Therapeutics28.34M
Entrada Therapeutics25.42M
LENZ Therapeutics17.50M
PureTech Health6.39M
Immutep5.28M
Revenue Rankings

ABSI News

More News